The Tuanku Ja'afar Hospital is a government hospital in Seremban, Negeri Sembilan, Malaysia. It is the largest hospital in Negeri Sembilan.

During the past decade, Hospital Tuanku Jaafar conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Tuanku Jaafar" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Hospital Sultanah Bahiyah" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "The George Institute" with 2 trials sponsored and "Ark Biosciences Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Tuanku Jaafar" #1 collaborator was "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator, "Hospital Queen Elizabeth, Malaysia" with 2 trials as a collaborator, "Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan" with 2 trials as a collaborator and "Hospital Raja Permaisuri Bainun" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Tuanku Jaafar" are "Arthritis, Psoriatic" (5 trials), "Depressive Disorder, Major" (4 trials), "Anosmia" (2 trials), "Arthritis, Rheumatoid" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Hospital Tuanku Jaafar" in a lesser frequency.

Most popular intervention types in "Hospital Tuanku Jaafar" are "Drug" (16 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Guselkumab" (5 trials), "CP-690,550" (2 trials), "Esketamine" (2 trials) and "Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Tuanku Jaafar" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Tuanku Jaafar". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Tuanku Jaafar, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Tuanku Jaafar, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".